Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01502280 : Fluorescence-guided Surgery for Low- and High-grade Gliomas
PhasePhase 3
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Presumed newly-diagnosed supratentorial glioma (previous biopsy-only/no adjuvant
therapy are eligible for randomization)

- Age > 18 years

- Normal bone marrow function (WBC > 3000, Platelets > 100,000)

Exclusion Criteria:

- Infratentorial tumors

- Pregnancy

- Hypersensitivity to 5-aminolevulinic acid hydrochloride or porphyrins

- History of photosensitivity, porphyria, or exfoliative dermatitis

- Hepatic dysfunction in the last 12 months (defined by AST, ALT, ALP, bilirubin > 2.5 x
normal)

- Serum creatinine > 180 µmol/L

- Estimated Glomerular Filtration Rate (eGFR) < 60 ml/min/1.73m2

- Inability to undergo MRI scan with contrast
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01502280      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740